News Related to Chronic Low Back Pain

Related coverage linked through entity extraction aliases.

FDA Approves First Posterior Motion-Preserving Device as DDD Pipeline Advances

Jul 01, 2026

The FDA approved the first posterior motion-preserving device for degenerative disc disease, while DiscGenics, Angitia, and BioRestorative advanced late-stage trials. ReGelTec reported positive HYDRAFIL data and CE Mark approval.

Eli Lilly Advances Oral Obesity Drug Pipeline Amid Intensifying Market Competition

Feb 18, 2026

Eli Lilly is developing multiple next-generation obesity treatments, including oral GLP-1 drug orforglipron expected to launch in Q2 2026, as competition intensifies in a market projected to reach $95 billion by 2030.